A phase 3 open-label, controlled, randomized trial evaluating the efficacy and safety of a bioengineered allogeneic cellularized construct in patients with deep partial-thickness thermal burns

Authors

Angela L F Gibson, University of Wisconsin
James H. Holmes IV, Wake Forest University
Jeffrey W. Shupp, Medstar Washington Hospital Center
David Smith, University of South Florida
Victor Joe, University of California at Irvine
Joshua Carson, University of Florida
Jeffrey Litt, University of Missouri Health Care
Steven Kahn, Medical University of South Carolina
Tracee Short, Baton Rouge General Medical Center
Leopoldo Cancio, United States Army Institute of Surgical Research
Julie Rizzo, United States Army Institute of Surgical Research
Jeffrey E. Carter, LSUSHC New OrleansFollow
Kevin Foster, Arizona Burn Center at MIHS
B Lynn Allen-Hoffmann, University of Wisconsin School of Medicine and Public Health

Document Type

Article

Publication Date

4-1-2021

Publication Title

Journal of Burn Care & Research

Volume

42(suppl_1)

Comments

Abstract Number: 31 American Burn Association 53rd Annual Meeting

Recommended Citation

Gibson, Angela L F; Holmes, James H. IV; Shupp, Jeffrey W.; Smith, David; Joe, Victor; Carson, Joshua; Litt, Jeffrey; Kahn, Steven; Short, Tracee; Cancio, Leopoldo; Rizzo, Julie; Carter, Jeffrey E.; Foster, Kevin; and Allen-Hoffmann, B Lynn, "A phase 3 open-label, controlled, randomized trial evaluating the efficacy and safety of a bioengineered allogeneic cellularized construct in patients with deep partial-thickness thermal burns" (2021). School of Medicine Faculty Publications. 1115.
https://digitalscholar.lsuhsc.edu/som_facpubs/1115
10.1093/jbcr/irab032.035